Expected Bayesian estimation for exponential model based on simple step stress with Type-I hybrid censored data.

The procedure of selecting the values of hyper-parameters for prior distributions in Bayesian estimate has produced many problems and has drawn the attention of many authors, therefore the expected Bayesian (E-Bayesian) estimation method to overcome these problems. These approaches are used based on the step-stress acceleration model under the Exponential Type-I hybrid censored data in this study. The values of the distribution parameters are derived. To compare the E-Bayesian estimates to the other estimates, a comparative study was conducted using the simulation research. Four different loss functions are used to generate the Bayesian and E-Bayesian estimators. In addition, three alternative hyper-parameter distributions were used in E-Bayesian estimation. Finally, a real-world data example is examined for demonstration and comparative purposes.

Statistical Inference under Censored Data for the New Exponential-X Fréchet Distribution: Simulation and Application to Leukemia Data.

In reliability studies, the best fitting of lifetime models leads to accurate estimates and predictions, especially when these models have nonmonotone hazard functions. For this purpose, the new Exponential-X Fréchet (NEXF) distribution that belongs to the new exponential-X (NEX) family of distributions is proposed to be a superior fitting model for some reliability models with nonmonotone hazard functions and beat the competitive distribution such as the exponential distribution and Frechet distribution with two and three parameters. So, we concentrated our effort to introduce a new novel model. Throughout this research, we have studied the properties of its statistical measures of the NEXF distribution. The process of parameter estimation has been studied under a complete sample and Type-I censoring scheme. The numerical simulation is detailed to asses the proposed techniques of estimation. Finally, a Type-I censoring real-life application on leukaemia patient's survival with a new treatment has been studied to illustrate the estimation methods, which are well fitted by the NEXF distribution among all its competitors. We used for the fitting test the novel modified Kolmogorov-Smirnov (KS) algorithm for fitting Type-I censored data.